Background Previous studies suggest that certain transition metal complexes, such as
cisplatin, are efficacious for treating various cancer types, including ovarian, lung, and …

GLOBOCAN 2012 estimates 14.1 million new cancer cases and 8.2 million cancer-related
deaths worldwide. Cancer is rapidly becoming a major public health concern in India as …

Background: Cancer is one of the main causes of death worldwide. Breast cancer is the
most prevalent type of cancer in women and the leading cause of cancer deaths due to its …

Cancer is rapidly becoming the top killer in the world. Most of the FDA approved anticancer
drugs are organic molecules, while metallodrugs are very scarce. The advent of the first …

Cancer is one of the major cases of death in the world. Current treatment of cancer is limited
to surgery, radiotherapy, and the use of cytotoxic agents, despite their well known side …

Triple-negative breast cancer (TNBC) is a highly aggressive breast cancer subtype. The
high rate of metastasis associated to the fact that these cells frequently display multidrug …

Ruthenium complexes are being considered as novel chemotherapeutic alternatives for
cancer treatment. In our study, we assessed the antitumoral activities of novel ruthenium …

There has been much interest in the development of transition metal-based complexes for
cancer therapy fueled by the success of cisplatin, a platinum (II) chemotherapeutic agent, in …

The effective clinical use of the three generation platinum anticancer drugs, cisplatin,
carboplatin, and oxaliplatin, has sparked interest in metallodrugs; however, drug resistance …

Glioblastomas (GBs) are highly aggressive and malignant brain tumors, which are highly
resistant to conventional multimodal treatments, leading to their abysmal prognosis. Herein …